Literature DB >> 8384566

Interaction of benzene 1,2,4-trisphosphate with inositol 1,4,5-trisphosphate receptor and metabolizing enzymes.

M Poitras1, S Bernier, G Boulay, A Fournier, G Guillemette.   

Abstract

In a wide variety of cells, inositol 1,4,5-trisphosphate (InsP3) is an important second messenger involved in the regulation of intracellular Ca2+ concentration. InsP3 interacts with specific receptors and triggers the release of sequestered Ca2+ from an internal store. We have synthesized a structural analogue of InsP3 by phosphorylation of the free hydroxyl groups of 1,2,4-benzenetriol with dibenzylphosphorochloridate. The product benzene 1,2,4-trisphosphate (BzP3) was shown to interact with InsP3 receptor and InsP3 metabolizing enzymes of bovine adrenal cortex. BzP3 competitively blocked InsP3 binding to adrenal cortex microsomes with a half-maximal efficiency at 34 microM. This affinity was about 10,000 times lower than that of InsP3 for its receptor. The Ca2+ releasing activity of BzP3 on the same microsomal preparation was monitored with the fluorescent indicator fura-2. BzP3 had no agonistic effect on this activity but it was able to inhibit InsP3-induced Ca2+ release in a dose-dependent manner. The activity of InsP3 phosphatase was also studied. BzP3 inhibited the activity of the phosphatase with a half-maximal efficiency of 32 microM. BzP3 was also able to inhibit the activity of the cytosolic InsP3 kinase with a half-maximal efficiency of 6.1 microM. These results show that BzP3 is interacting with the three specific recognition sites for InsP3 in the bovine adrenal cortex. The inhibitory effect of this compound is relatively more potent on the metabolizing enzymes than on the Ca(2+)-mobilizing receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384566     DOI: 10.1016/0922-4106(93)90145-y

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Benzene polyphosphates as tools for cell signalling: inhibition of inositol 1,4,5-trisphosphate 5-phosphatase and interaction with the PH domain of protein kinase Balpha.

Authors:  Stephen J Mills; Fabrice Vandeput; Melanie N Trusselle; Stephen T Safrany; Christophe Erneux; Barry V L Potter
Journal:  Chembiochem       Date:  2008-07-21       Impact factor: 3.164

2.  Multivalent benzene polyphosphate derivatives are non-Ca2+-mobilizing Ins(1,4,5)P3 receptor antagonists.

Authors:  Stephen J Mills; Tomas Luyten; Christophe Erneux; Jan B Parys; Barry V L Potter
Journal:  Messenger (Los Angel)       Date:  2012-12-01

3.  Pancreatic acinar-cell desensitization alters InsP3 production and Ca2+ mobilization under conditions where InsP3 receptor remains intact.

Authors:  M Servant; G Guillemette; J Morisset
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

4.  The discovery and development of IP3 receptor modulators: an update.

Authors:  Jessica Gambardella; Marco B Morelli; Xujun Wang; Vanessa Castellanos; Pasquale Mone; Gaetano Santulli
Journal:  Expert Opin Drug Discov       Date:  2021-01-06       Impact factor: 7.050

5.  Combined Pharmacophore and Grid-Independent Molecular Descriptors (GRIND) Analysis to Probe 3D Features of Inositol 1,4,5-Trisphosphate Receptor (IP3R) Inhibitors in Cancer.

Authors:  Humaira Ismatullah; Ishrat Jabeen
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

6.  Allosteric Site on SHIP2 Identified Through Fluorescent Ligand Screening and Crystallography: A Potential New Target for Intervention.

Authors:  Hayley Whitfield; Andrew M Hemmings; Stephen J Mills; Kendall Baker; Gaye White; Stuart Rushworth; Andrew M Riley; Barry V L Potter; Charles A Brearley
Journal:  J Med Chem       Date:  2021-03-16       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.